Severe hyponatremia associated with the combined use of thiazide diuretics and selective serotonin reuptake inhibitors.
Thiazide diuretics and selective serotonin reuptake inhibitors (SSRIs) are among the most commonly prescribed medications. Each medication has been associated with the development of severe hyponatremia. The mechanisms involved in the development of hyponatremia differ for each medication. Thiazide diuretics induce hyponatremia by impairment of urinary dilution, renal loss of sodium and potassium, stimulation of antidiuretic hormone (ADH), and perhaps from a dipsogenic effect. SSRIs cause hyponatremia through the syndrome of inappropriate ADH release. Two cases of severe hyponatremia in patients taking both a thiazide diuretic and an SSRI highlight the possibility of a synergistic effect in impairment of renal free water clearance when both medications are given. These two cases serve as a cautionary example and should prompt careful monitoring of patients prescribed both an SSRI and a thiazide diuretic (especially in elderly women, who seem to be at increased risk for this complication).
Rosner
Mitchell H
MH
Mercer University Medical School, Medical Associates of Savannah, Savannah, GA 31416, USA. rosner@medscape.com
D000368:Aged; D000369:Aged, 80 and over; D003863:Depression / Q000150:complications / Q000188:drug therapy; D004232:Diuretics; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000009:adverse effects; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007010:Hyponatremia / Q000139:chemically induced*; D008875:Middle Aged; D017374:Paroxetine / Q000009:adverse effects; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D020280:Sertraline / Q000009:adverse effects; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects*
D004232:Diuretics; D006852:Hydrochlorothiazide; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline; D049993:Sodium Chloride Symporter Inhibitors